4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-013882
Options or other derivatives
- EVP, Chief Legal Officer acquired 130,718 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Daly Jason B. EVP, Chief Legal Officer | 2026-03-02 | Grant or award · Restricted Stock Units | +65,359 | 65,359 | D | ||
| Daly Jason B. EVP, Chief Legal Officer | 2026-03-02 | Grant or award · Performance-Based Restricted Stock Units | +65,359 | 65,359 | D | ||
Loading xslF345X05/wk-form4_1772573232.xml…